Carros, France

Virbac Corporation


USPTO Granted Patents = 48

% Expired Patents = 12.5



Trademarks = 63

Forward Citations = 208

Loading Chart...
Loading Chart...

71 inventors (with patents filed for the assignee):

goldMedal Guy Derrieu (8 out of 22 patents)

silverMedal Michel Robin (7 out of 7 patents)

bronzeMedal Thomas A Miller (4 out of 4 patents)

4 Laurent Rodrigues (3 out of 3 patents)

5 Arnaud Steiner (3 out of 3 patents)

6 Patricia Monginoux (3 out of 3 patents)

7 Fanny Martins (3 out of 3 patents)

8 Nathalie Delhom (3 out of 3 patents)

9 Bertrand Havrileck (3 out of 4 patents)

10 Albert Ahn (3 out of 14 patents)

11 Ian Cottrell (3 out of 21 patents)

12 Benoît Berny (2 out of 2 patents)

13 Jean-Michel Brunel (2 out of 8 patents)

14 Jean-Pascal Marc (2 out of 2 patents)

15 Nicolas Brunel (2 out of 2 patents)


Core Competencies:
Glucocorticoids
Epithelial Infections
Veterinary Compositions
Squalamine Derivatives
Topical Compositions
Sustained Release Vaccines
Anthelmintic Formulations
Behavioral Disorders
Portable Fluid Dispenser
External Parasite Control
Nutritional Oral Compositions
Impact-Protection Devices

48 patents:

Virbac Corporation is a global animal health company that offers a wide range of pharmaceutical and biotechnological veterinary products. With a focus on research and development, Virbac strives to provide innovative solutions to animal health challenges. Their products span various categories such as vaccines, medications, dermatology, and dental care, catering to the needs of both companion and production animals. Committed to ethical practices and sustainability, Virbac operates in over 100 countries, contributing to the well-being of animals worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Virbac Corporation
48 Patents

#1 in Carros

#489 in France

#14,507 in the World

Carros, FR
Carros, France
Forward Citations = 208

71 inventors:

Please report any incorrect information to [email protected]
Loading…